Welcome!

News Feed Item

Bayer commends AHS and CAPC for updated heartworm guidelines

Important guideline revisions made by both parasite-focused organizations address heartworm prevention, treatment and diagnosis; and include information about FDA approval of the first-ever treatment for circulating microfilaria

SHAWNEE, Kan., Jan. 19, 2014 /PRNewswire/ -- Veterinarians wanting to keep their heartworm protocols up to date should check out the latest information from the American Heartworm Society (AHS) and the Companion Animal Parasite Council (CAPC), say representatives from the Bayer HealthCare LLC Animal Health division. New information on heartworm prevention, diagnosis and treatment recently prompted changes to the guidelines veterinarians rely on when establishing their heartworm protocols. Both AHS and CAPC have announced updates to their heartworm guidelines, citing—among other factors—new information about the documented presence of resistant sub-populations of heartworms.

"At Bayer, we commend these two organizations for their decision to revise their recommendations," said Cristiano von Simson, DVM, MBA, director of Veterinary Technical Services at Bayer HealthCare LLC Animal Health division, North America. The AHS guidelines reinforce the importance of year-round administration of heartworm preventives, support the administration of doxycycline and macrocyclic lactones prior to adulticide therapy and recommend both antigen and microfilaria testing. In addition, the AHS guidelines also referenced the recent U.S. Food and Drug Administration's (FDA) approval of Bayer's Advantage Multi® for Dogs (imidacloprid + moxidectin) as the first and only product labeled for circulating microfilaria treatment in heartworm positive dogs in the United States.

"Bayer is passionate about caring for animals and develops products and services that support veterinarians' ability to keep our pets healthy," said von Simson. "These updated guidelines, and the FDA's recognition of the importance of treating microfilaria, will strengthen veterinarians' capability to reduce the incidence and severity of heartworm disease in dogs."

According to the American Heartworm Society, there are conservatively 1 million cases of heartworm disease diagnosed in dogs every year.1 Heartworm disease most commonly results in abnormal functioning of the lungs, heart, liver and kidneys.2

New information on resistance, Wolbachia and diagnostic testing drive AHS updates
"AHS continually seeks the latest information when it comes to understanding and preventing heartworm disease," says Stephen Jones, DVM, President of the American Heartworm Society, noting that the latest update reflects information and research presented during the 2013 Triennial Heartworm Symposium. "Like the practitioners we serve, we need to be prepared to adjust our recommendations as new information becomes available. This past year was significant in terms of identifying new information about diagnosis, prevention and treatment of heartworm disease."

The American Heartworm Society's mission is to lead the veterinary profession, as well as further scientific progress in the study of heartworm disease, inform its members of new developments and help promote effective procedures for diagnosis, treatment and prevention of heartworm disease. The AHS' complete canine heartworm guidelines may be found at http://www.heartwormsociety.org/veterinary-resources/canine-guidelines.html.

The updated AHS feline guidelines can be found at: http://www.heartwormsociety.org/veterinary-resources/feline-guidelines.html.

Companion Animal Parasite Council revises heartworm guidelines for canines
Last month the Companion Animal Parasite Council published their latest revisions to the heartworm prevention and treatment guidelines which continue to advocate for year-round heartworm prevention for dogs and cats. This recommendation is based on parasite behaviors and human behaviors related to heartworm prevention. Like many other diseases, heartworm is much easier and less expensive to prevent than to treat. Consequently, pet owners should be educated about prevention and strongly encouraged to improve compliance by keeping up with year-round prevention.

"Given the very effective preventives available, dogs and cats shouldn't develop heartworm disease," says Susan E. Little, DVM, Ph.D., Professor of Parasitology at Oklahoma State University and President-elect of CAPC. "Nonetheless, a large number of pets continue to become infected each year due, in part, to the varying activity times and behaviors of the mosquitoes that transmit heartworm, making it impossible to target transmission seasons or locations precisely. Year-round prevention is of utmost importance."

The Companion Animal Parasite Council (CAPC) aims to foster animal and human health, while preserving the human-animal bond, through recommendations for the diagnosis, treatment, prevention and control of parasitic infections. CAPC's complete canine heartworm guidelines may be found here: http://www.capcvet.org/capc-recommendations/canine-heartworm/.

About Advantage Multi® for Dogs
For more information on Advantage Multi® for Dogs, visit http://www.bayerdvm.com/show.aspx/productdetail/advantage-multi-for-dogs
Product Label

CAUTION: Federal (U.S.A.) law restricts this drug to use by or on the order of a licensed veterinarian. WARNING: DO NOT ADMINISTER THIS PRODUCT ORALLY. For the first 30 minutes after application ensure that dogs cannot lick the product from application sites on themselves or other treated animals. Children should not come in contact with the application sites for two (2) hours after application. (See Contraindications, Warnings, Human Warnings, and Adverse Reactions, for more information.) CONTRAINDICATIONS: Do not use this product on cats.

About Bayer HealthCare
The Bayer Group is a global enterprise with core competencies in the fields of health care, agriculture and high-tech materials. Bayer HealthCare, a subgroup of Bayer AG with annual sales of EUR 18.6 billion (2012), is one of the world's leading, innovative companies in the healthcare and medical products industry and is based in Leverkusen, Germany. The company combines the global activities of the Animal Health, Consumer Care, Medical Care and Pharmaceuticals divisions. Bayer HealthCare's aim is to discover, develop, manufacture and market products that will improve human and animal health worldwide. Bayer HealthCare has a global workforce of 54,900 employees (Dec. 31, 2012) and is represented in more than 100 countries. More information at www.healthcare.bayer.com.

Contact:

Staci Gouveia, Tel. 913.268.2577
Email: [email protected]

Lauren Dorsch, Tel. 913.268.2747
Email: [email protected]

Find more information about Bayer HealthCare Animal Health at
www.animalhealth.bayerhealthcare.com
Follow us on Twitter: @Bayer4animalsUS
Follow us on Facebook: http://www.facebook.com/healthcare.bayer  

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer's public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

1Weyenberg, K. (2009). Team Up Against Heartworm. The Team, pg. 10-12.
2American Heartworm Society, Pet Owner Glossary, http://www.heartwormsociety.org/pet-owner-resources/glossary.html. Accessed October 6, 2013.

SOURCE Bayer HealthCare Animal Health

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
Join IBM November 1 at 21st Cloud Expo at the Santa Clara Convention Center in Santa Clara, CA, and learn how IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Cognitive analysis impacts today’s systems with unparalleled ability that were previously available only to manned, back-end operations. Thanks to cloud processing, IBM Watson can bring cognitive services and AI to intelligent, unmanned systems. Imagine a robot vacuum that becomes your personal assistant tha...
Cloud Expo, Inc. has announced today that Andi Mann and Aruna Ravichandran have been named Co-Chairs of @DevOpsSummit at Cloud Expo Silicon Valley which will take place Oct. 31-Nov. 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. "DevOps is at the intersection of technology and business-optimizing tools, organizations and processes to bring measurable improvements in productivity and profitability," said Aruna Ravichandran, vice president, DevOps product and solutions marketing...
The next XaaS is CICDaaS. Why? Because CICD saves developers a huge amount of time. CD is an especially great option for projects that require multiple and frequent contributions to be integrated. But… securing CICD best practices is an emerging, essential, yet little understood practice for DevOps teams and their Cloud Service Providers. The only way to get CICD to work in a highly secure environment takes collaboration, patience and persistence. Building CICD in the cloud requires rigorous a...
SYS-CON Events announced today that IBM has been named “Diamond Sponsor” of SYS-CON's 21st Cloud Expo, which will take place on October 31 through November 2nd 2017 at the Santa Clara Convention Center in Santa Clara, California.
In his Opening Keynote at 21st Cloud Expo, John Considine, General Manager of IBM Cloud Infrastructure, will lead you through the exciting evolution of the cloud. He'll look at this major disruption from the perspective of technology, business models, and what this means for enterprises of all sizes. John Considine is General Manager of Cloud Infrastructure Services at IBM. In that role he is responsible for leading IBM’s public cloud infrastructure including strategy, development, and offering ...
SYS-CON Events announced today that N3N will exhibit at SYS-CON's @ThingsExpo, which will take place on Oct 31 – Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. N3N’s solutions increase the effectiveness of operations and control centers, increase the value of IoT investments, and facilitate real-time operational decision making. N3N enables operations teams with a four dimensional digital “big board” that consolidates real-time live video feeds alongside IoT sensor data a...
Gemini is Yahoo’s native and search advertising platform. To ensure the quality of a complex distributed system that spans multiple products and components and across various desktop websites and mobile app and web experiences – both Yahoo owned and operated and third-party syndication (supply), with complex interaction with more than a billion users and numerous advertisers globally (demand) – it becomes imperative to automate a set of end-to-end tests 24x7 to detect bugs and regression. In th...
In a recent survey, Sumo Logic surveyed 1,500 customers who employ cloud services such as Amazon Web Services (AWS), Microsoft Azure, and Google Cloud Platform (GCP). According to the survey, a quarter of the respondents have already deployed Docker containers and nearly as many (23 percent) are employing the AWS Lambda serverless computing framework. It’s clear: serverless is here to stay. The adoption does come with some needed changes, within both application development and operations. Tha...
SYS-CON Events announced today that Avere Systems, a leading provider of enterprise storage for the hybrid cloud, will exhibit at SYS-CON's 21st International Cloud Expo®, which will take place on Oct 31 - Nov 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. Avere delivers a more modern architectural approach to storage that doesn't require the overprovisioning of storage capacity to achieve performance, overspending on expensive storage media for inactive data or the overbui...
With major technology companies and startups seriously embracing Cloud strategies, now is the perfect time to attend 21st Cloud Expo October 31 - November 2, 2017, at the Santa Clara Convention Center, CA, and June 12-14, 2018, at the Javits Center in New York City, NY, and learn what is going on, contribute to the discussions, and ensure that your enterprise is on the right path to Digital Transformation.
Companies are harnessing data in ways we once associated with science fiction. Analysts have access to a plethora of visualization and reporting tools, but considering the vast amount of data businesses collect and limitations of CPUs, end users are forced to design their structures and systems with limitations. Until now. As the cloud toolkit to analyze data has evolved, GPUs have stepped in to massively parallel SQL, visualization and machine learning.
We all know that end users experience the Internet primarily with mobile devices. From an app development perspective, we know that successfully responding to the needs of mobile customers depends on rapid DevOps – failing fast, in short, until the right solution evolves in your customers' relationship to your business. Whether you’re decomposing an SOA monolith, or developing a new application cloud natively, it’s not a question of using microservices – not doing so will be a path to eventual b...
The dynamic nature of the cloud means that change is a constant when it comes to modern cloud-based infrastructure. Delivering modern applications to end users, therefore, is a constantly shifting challenge. Delivery automation helps IT Ops teams ensure that apps are providing an optimal end user experience over hybrid-cloud and multi-cloud environments, no matter what the current state of the infrastructure is. To employ a delivery automation strategy that reflects your business rules, making r...
Digital transformation is changing the face of business. The IDC predicts that enterprises will commit to a massive new scale of digital transformation, to stake out leadership positions in the "digital transformation economy." Accordingly, attendees at the upcoming Cloud Expo | @ThingsExpo at the Santa Clara Convention Center in Santa Clara, CA, Oct 31-Nov 2, will find fresh new content in a new track called Enterprise Cloud & Digital Transformation.
Most technology leaders, contemporary and from the hardware era, are reshaping their businesses to do software. They hope to capture value from emerging technologies such as IoT, SDN, and AI. Ultimately, irrespective of the vertical, it is about deriving value from independent software applications participating in an ecosystem as one comprehensive solution. In his session at @ThingsExpo, Kausik Sridhar, founder and CTO of Pulzze Systems, will discuss how given the magnitude of today's applicati...